-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RUdbOPxDN+aZMGn7Tblvy2d9yo4mtNXT1oGnbyyohydqC5rhqTTFIVnjXuguJBJP /LVdd0ETk9CAFKw389s2Lw== 9999999997-09-024348.txt : 20090902 9999999997-09-024348.hdr.sgml : 20090902 20090902100613 ACCESSION NUMBER: 9999999997-09-024348 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20090902 DATE AS OF CHANGE: 20090902 20090902 20090902 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IMMUNEX CORP /DE/ CENTRAL INDEX KEY: 0000719529 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 510346580 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 000-12406 FILM NUMBER: 091049944 BUSINESS ADDRESS: STREET 1: 51 UNIVERSITY ST CITY: SEATTLE STATE: WA ZIP: 98101 BUSINESS PHONE: 2065870430 MAIL ADDRESS: STREET 1: 51 UNIVERSITY STREET CITY: SEATLE STATE: WA ZIP: 98101 CT ORDER 1 filename1.pdf begin 644 filename1.pdf M)5!$1BTQ+C0-)>+CS],-"C8@,"!O8FH-/#PO3&EN96%R:7IE9"`Q+TP@-SDT M,B]/(#@O12`S-S0T+TX@,2]4(#!F\W!8[W?I6O:K`9@$:`Z M/E:H/BL@!K)E+D+$&5X!!!@`0*X'T@T*96YD%LP(#`@-C$R(#%LP(#`@-C$R(#P4]=M/&>-X8+AEF-V05'&FER6IE M3`.],C;CRR3Y^ZWJ]@4(&:+$W8WK=LZIZGRZ6[NP+WI?PMZG,.3@0KCKN1P< M_,''T!F![XS96$!X[#FPQ]\PIC\O/0OL\#]<#ESF>A#.ZH/!D`5CKSL=,,=Q MQV15+UYZWZVGU3*T(&?K^?3I<1DN;7Q9D.5D-0/T/D2G?T^_3E9W]0:F#_?WR_5Z^;`RWD=L M/#Q+E7P**"+7,M3*8\;F0/O`W>4U*AX+1E=9!TW6@S!FKO4X687+U1TFN%KHS%S.A$`.&FM>6WO<6"]G<[28_`GAXWP2 MWN.FQ@L-1]Y53;P!G2*&7^?0((98S6N$8#(-X6$!;C`D.K@E:H<>\X7W<:4( MA#>^#.CU4J7V&:Y2>FC89,\(]=(HV>.)/50B425AD#](CU">1] M`-/%;[CR?),$0[8Z@W]O??2+J'%A-$Y`^:8NT8G7N:QDV%8R-!""/>"^YUB3 MHTVT[67:AV4:,WBVBBJ.95%D.909G)5LZ`P81Q2=,T;BEEBL^\2>;2BJS5&5 MI=Q"E$)T.B4JCDJ5I5"E6]3?8X4P&/$9;Q^`;G3+Q6;`(9<_*EF4*MV33_E: MRK0@C]D.(CCE\J?2\(V8ZYZ)3312%=I55A6PSZ.T)+,X2W=J2U8^\_RN)+=- M8%BWI4Q+%250YC(J":Z`3F"'`!EA<6S)\5457EN%9YRH%`W(>F@9+"[%)%_C MI-HB8KL\,V]!>9#08.[X-S&OA]#\]:`VJBR(L`@6.HX%X\$?L$/%;0&C?:N2 M-^"BWS27<7E+N6X0C(RXP]]K,>'B8J(8.#L1?8D*$R672$6!Z.@2"]B\@188 M[P365"3\#O%V4M5NRT-DT^PL;4R0T]X>6:H`Q-`65F:[ED9R7"/YHXH21=\H M68"Q+&@$=[4*_Y>S\;MEQ%`3'6?'H\QC6B+'.Y5&J=YH"FDVCRQ35&2*\5D0 M=.R\8_Y,^43I(I=RVW",.EPV7CWK7!Z3N&S)T@%N][-K)I,'3VS-I@P\CS]; MFV?[V1+/=E\'G*F?JND5$EN61Z5N%E]?&FWBHQ:4F@>R6>CJ)1RB`K:RE!IX M1#I%PM.L),6=J@TV.,JKS?;B+G+:5'4[65M5Q$E62%`E`RPSSO(MMG7RUC<3 MT&'\7.Q=I355;:>T=/B6&6(&N+J!W/,&PCOHC*'KL;[+DB1[H=$B32/!BTH2 M7=ZF'E0<9^SHZG\!O#9U0KE,I&X`Q()"&CST?*!MJ8ZV3S.#Q(Q9G62NLBT4 M)QFKG9+;SR9'[+'KZZ-N.]WN&%\$=;L#0-WQ8.O^(\S`=@/A4=%Y5NT/]3>Z M[-@$5=[11[1Y>K"M)?G7365MD9Q_INZ@J#UFNRK?/ M#;HW`'^_:'#1N./G+P+1U=W/?3'$87.D$U0]4HPG-)<26M!)U)S4T'^E!T?C MS.Q?FOU[TW;1ZJ/)8-UD<#).6MNX6:AW\<^\:9NI#MRD4='#LU*S*^C=X&92 MEUHU&,W#WO\"#`!"`-@Q"@T*96YD7!E+U1R=654>7!E+T9O;G1$97-C7!E M+U!A9V5S+TMI9'-;."`P(%)=/CX-96YD;V)J#30@,"!O8FH-/#PO4W5B='EP M92]834PO3&5N9W1H(#,V,#(O5'EP92]-971A9&%T83X^G)E4WI.5&-Z:V,Y M9"(_/@H\>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM M<'1K/2)!9&]B92!835`@0V]R92`T+C`M8S,Q-B`T-"XR-3,Y,C$L(%-U;B!/ M8W0@,#$@,C`P-B`Q-SHQ-#HS.2(^"B`@(#QR9&8Z4D1&('AM;&YS.G)D9CTB M:'1T<#HO+W=W=RYW,RYO&%P.D-R96%T941A=&4^,C`P.2TP.2TP,E0Q,#HP M-3HS,2TP-#HP,#PO>&%P.D-R96%T941A=&4^"B`@("`@(#PO&%P34TZ26YS=&%N8V5)1#YU=6ED.C)F.#(R9#4W+68U8F0M-#(X M,2UB.38W+3(T-6(Q-&0W.64S.#PO>&%P34TZ26YS=&%N8V5)1#X*("`@("`@ M/"]R9&8Z1&5S8W)I<'1I;VX^"B`@(#POF4@-CX^#0IS 6=&%R='AR968-"C$Q-@T*)25%3T8-"C\_ ` end -----END PRIVACY-ENHANCED MESSAGE-----